Technology Startup

Sponsors: Troutman Pepper

Criteria:

• Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.

Key Considerations:

• Product or service innovation including market need or assessment.
• Potential for significant growth.
• The management team and its ability and record of achieving success.
• A demonstration of success such as significant milestones, raising capital, and revenue.

Technology Emerging

Sponsors: Fox Rothschild LLP

Criteria:

• Company must have been in operation before January 1, 2018. Revenues must be less than $50 million, except in the most recent fiscal year.

Key Considerations:

• Product or service innovation, including proprietary technology or other advantage.
• Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
• Strength of management team including ability to raise capital.
• Profitability or demonstrated ability to achieve profitability (e.g. strategy to achieve break even, the ability to realize high gross margins, etc.), and decisions that led to corporate collaborations or license deals.

Technology CEO

Sponsor: Cozen O’Connor

Criteria:

• Individual’s background (CV/Bio required) and the company’s success to date.

Key Considerations:

• CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
• Leadership and impact in industry and/or market.
• Ability to attract and retain talent.
• Company milestones including financial accomplishments and a strategy for continued company success.
• Community and/or industry involvement.
• Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the tech industry in the region.

Technology Company

Sponsor: Comcast Business

Criteria:

• Company with more than $50 million in revenues in the most recently completed fiscal year.

Key Considerations:

• Leadership and product and/or service innovation in an industry or market.
• Significant company milestones including financial accomplishments.
• Community and industry involvement.

Investment Deal

Sponsor: EPAM and Baker Tilly

Criteria:

• Deal must have been fully executed between January 1, 2021 and December 31, 2021.
• Events that qualify for this category include Exit Transaction (e.g. IPO), Capital Raising Transaction (e.g. financing: debt, mezzanine, equity; recap), Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

• Brief history and/or background of the deal.
• Key deal stats (transaction size, valuation, valuation multiple, value to shareholders).
• Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
• How did the sale or purchase impact the broader industry(s) of the buyer and/or seller?
• Provide a brief business description including offerings, first-mover advantages, competitive barriers, and any unique asset(s), IP, technology, etc.
• Provide a brief history of business from its inception – especially as it relates to results from invested capital (if transaction was a sale).
• What amount was invested from the inception and its uses. How much was invested in unique technology or other assets?

Life Sciences & Healthcare Startup

Sponsor: Ben Franklin Technology Partners

Criteria:

• Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.

Key Considerations:

• Discuss product innovation including market need/assessment and potential for significant growth.
• Discuss the management team and its ability and record of achieving success.
• Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
• Describe the R&D investment strategy.
• What did the company do to overcome challenges in financing, development or commercialization?

Life Sciences & Healthcare Emerging

Sponsor: RSM US LLP and SAP

Criteria:

• Company must have been in operation before January 1, 2018. Must have sales, grants, or licensing fees. The Company should have no more than 3 years of operating results since its founding.

Key Considerations:

• Describe product, including proprietary applications or other advantage.
• What animal or OUS (outside of the United States) clinical work has been done to prove the technology?
• Describe the impact on the clinical problem this technology is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
• Address the strength of the management team including ability to raise capital.
• Profitability or demonstrated ability to achieve profitability (e.g., strategy to achieve break even, ability to realize high gross margins, etc.) or decisions that led to corporate collaborations or license deals.

Life Sciences & Healthcare CEO

Sponsors: EY and Morgan Lewis

Criteria:

• Individual’s background (CV/Bio required) and the company’s success to date.

Key Considerations:

• Describe CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
• Leadership and impact in industry and/or market.
• Ability to attract and retain talented resources.
• Company milestones including financial accomplishments and a strategy for continued company success.
• Community/industry involvement.
• Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.

Life Sciences & Healthcare Company

Criteria:

• Company must have at least four years of operating results in industry segments such as specialty pharmaceuticals, biotechnology, medicaldevices/instrumentation, therapeutics and diagnostics.

Key Considerations:

• Compnay should demonstrate its ability to raise capital; generate revenue; and commercialization and/or strategy to enter into substantive strategic alliances.
• Company should demonstrate its development strategy and clinical pathway to development.
• Describe any significant events, e.g. product discovery, drug registration, an exit, an increase in sales etc. that occurred in 2021.
• What did the company do to overcome challenges in financing, development, or commercialization?

Healthcare Innovator

Sponsor: Independence Blue Cross

Criteria:

• The nominee can be a company, researcher, investor, or individual providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.

Key Considerations:

• The nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth.
• The nominee should be able to demonstrate return on investment or clinical impact of its solution.
• The nominee can be in any sector (technology, life sciences, investment, health care delivery, etc.), but must be serving the healthcare industry in Greater Philadelphia.
• The nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowering costs.

Legend Award (Lifetime Achievement)

Sponsor: Cigniti Technologies and Grant Thornton LLP

The Legend Award for Lifetime Achievement is presented to an individual who has forwarded technology and sciences in the region through leadership and exemplary work. The Legend recipient must have a strong connection to the community, a history of personal accomplishments and a track record of success.

The Tribute Journal will provide you with more information on each award, finalists, sponsors and tributes. It is an ideal opportunity to recognize our honorees and finalists at the Enterprise Awards by honoring them in the context of a memorable message.

Technology Judges

• Jared Blitzstein
  Director of Software Engineering
  Boomi
• Greg Doran  
  CFO
  Frontline Education
• Sean Dowling
  Partner
  Osage Venture Partners
• Shintaro Kaido
  Vice Provost for Innovation & Executive Director, Drexel Applied Innovation
  Drexel University
• Brian Kim
  Partner
  NewSpring Capital
• Kalyana Rao Konda
  President, NA East
  Cigniti Technologies
• Brian McCabe
  Senior Director, Technology Finance
  BridgeBank
• Dan Klein
  Managing Director
  Slalom
• Nihan Rahman
  Managing Director
  Instamed, a JP Morgan Company
• Nassar Nizami
  CIO
  Jefferson University/Einstein
• Debbie O’Brien
  SVP, Market Manager
  Bank of America
• Pooja Ojala
  Vice President, Strategy
  Veeva
• Daphne Thomas
  COO
  iPipeline
• April Walker
  Sr. Director,
  US Microsoft Technology Centers

Life Sciences & Healthcare Judges

• Kevin Brophy
  Life Sciences Industry Principal
  SAP
• Carol Burnes
  CEO
  Cagent Vascular
• Greg Cathcart 
  CEO 
  Excellis Health Solutions
• Victor Caraballo
  Vice President Quality Management
  Independence Blue Cross
• Gerianne DiPiano
  CEO
  FemmePharma
• Lawana Dumas
  Director, Oncology Strategic Alliances
  Merck
• Lalo Flores
  CEO
  Century Therapeutics
• Shahram Hejazi
  Managing Director and CEO
  BioAdvance
• Dr. Calvin Knowlton
  CEO, Chairman & Founder
  Tabula Rasa
• Maria Maccecchini
  CEO
  Annovis Bio
• Matthew Reber
  Partner
  1315 Capital
• Heather Steinman
  VP, Business Development and Executive Director of Technology Transfer
  The Wistar Institute
• Zev Sunleaf
  Vice President, Office of Technology Transfer, Commercialization & Innovation
  Children’s Hospital of Philadelphia

• Life Sciences & Healthcare Startup
  • Avisi Technologies
  • Envara Health
  • The Discovery Labs

Sponsor:  Ben Franklin Technology Partners

• Technology Startup
  • Crossbeam
  • Grovara
  • PatientWing

Sponsors:  Troutman Pepper

• Investment Deal
  • Passage Bio
  • TrialScope
  • Vertex

Sponsors:  Baker Tilly and EPAM

• Life Sciences & Healthcare Emerging
  • Antares Pharma
  • Incyte
  • Myonex

Sponsor:  RSM and SAP

• Technology Emerging
  • Greenphire
  • Infinite Blue
  • IntegriChain

Sponsor:  EisnerAmper and Fox Rothschild

• Life Sciences & Healthcare CEO
  • Annovis Bio, Maria Maccecchini, PhD
  • Astarte Medical, Tracy Warren
  • MOBILion Systems, Melissa Sherman, PhD

Sponsor: EY and Morgan Lewis & Bockius

• Technology CEO
  • iPipeline, Larry Berran
  • Frontline Education, Mark Gruzin
  • Odessa, Madhu Natarajan

Sponsors:  Cozen O’Connor

• Healthcare Innovator
  • AnaOno
  • Genomind
  • NeuroFlow

Sponsor:  Independence Blue Cross

• Technology Company
  •  AGI, An Ansys Company
  • Relay Network
  • Suvoda

Sponsor:  Comcast Business

2021 Legend Award Honoree

Sponsored by: Cigniti Technologies and Grant Thornton

Josh Kopelman

First Round Capital

Josh is Founding Partner of First Round Capital, one of the leading seed-stage venture funds in the country, including 25 investments in local companies. Josh has consistently ranked in the top 20 of Forbes annual “Midas List” of the top 100 tech investors. Before becoming a venture capitalist, Josh founded three companies: In 1992 Josh co-founded Infonautics Corporation – taking it public in 1996. Josh co-founded Half.com in 1999 and led the company through its acquisition by eBay. And in 2003 Josh helped to found TurnTide, an anti-spam company that was acquired by Symantec. Josh is an inventor on over a dozen U.S. Patents for his work in Internet technology. On a local level, Josh also serves as Chairman of the Board for The Philadelphia Inquirer, LLC and is a member of the board of directors of the Ed Snider Youth Hockey Foundation.

The Enterprise Awards, presented by Fairmount Partners and KPMG LLP, recognize and honor leadership and outstanding achievement in the technology, healthcare and life science industries throughout the region. Nominations for 2022 are now open.

Nomination Form